Article Abstract

Immunotherapy in urothelial carcinoma: fade or future standard?

Authors: Johannes Breyer, Maximilian Burger, Wolfgang Otto

Abstract

Immunotherapy of non-muscle-invasive bladder carcinoma by Bacillus-Calmette-Guérin (BCG) instillation is a well-established treatment option since decades. Despite this fact, the immunocellular basis was first studied in recent years. New aspects of immunotherapy, also for progressed bladder carcinoma, might follow promising research on immunological targets.